Psychosocial factors are associated with prolonged hospitalization in a population with advanced HIV

International Journal of STD and AIDS

Volumn 12, Issue 5, 2001, Pages 302-306

  Cheng, Allen C ^a,b   Mijch, Anne M ^b   Jennifer F, Hoy ^b   Wesselingh, Steven L ^b   Fairley, Christopher K ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b ALFRED HOSPITAL   (Australia)

Author keywords

Acquired immunodeficiency syndrome; HIV infections; Hospitalization; Mental disorders; Morbidity; Mortality; Social environment; Substance related disorders

Indexed keywords

ADULT; ARTICLE; DATA BASE; FEMALE; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; PSYCHOSOCIAL DISORDER; SOCIAL PSYCHOLOGY; STATISTICAL MODEL;

CROSS-SECTIONAL STUDIES; HIV INFECTIONS; HOSPITALIZATION; HUMANS; LENGTH OF STAY; PATIENT DISCHARGE; PSYCHOLOGY; TIME FACTORS;

EID: 0035008710     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462011923129     Document Type: Article

References (16)

1. 1 Palella FJ, Delaney KM, Moorman AC, et al. for the HIV Outpatient Study Investigators. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-60
2. 2 Correll PK, Law MG, McDonald AM, Cooper DA, Kaldor JM. HIV disease progression in Australia at the time of combination antiretorviral therapies. Med J Aust 1998;169:469-72
3. 3 Egger M, Hirschel B, Francioli P, et al. Impact of new antiretrovrial combination therapies in HIV infected patients in Switzerland: prospective multicentre study: Swiss HIV Cohort Study. BMJ 1997:315:1194-9
4. 4 Mouton Y, Alfandari S, Valette M, et al. (Federation National des Centres de Lutte contra le SIDA). Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. AIDS 1997;11:F101-F105
5. 5 Torres RA, Barr M. Impact of combination therapy for HIV infection on inpatient census. N Engl J Med 1997;336:1531-2
6. 6 Mellors JW, Munoz A, Giorgi JV, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997;126:946-54
7. 7 Delta Co-ordinating Committee and Virology Group. An evaluation of HIV RNA and CD4 cell count as surrogates for clinical outcomes. AIDS 1999;13:565-73
8. 8 Hughes MD, Johnson VA, Hirsch MS, et al. for the ACTG 241 Protocol Virology Substudy Team. Monitoring plasma HIV-1 RNA levels in addition to CD4 lymphocyte count improves assessment of antiretoviral therapeutic response. Ann Intern Med 1997;126:929-38
9. 9 O'Brien WA, Hartigan PM, Daar ES, Simberkoff MS, Hamilton J for the VA Cooperative Study on AIDS. Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. Ann Intern Med 1997;126:939-45
10. 10 O'Brien WA, Hartigan PM, Martin D, et al. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med 1996;334:426-31
11. 11 Stewart GJ. 'You've gotta have HAART'. Med J Aust 1998;169:456-7
12. 12 National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, Hepatitis C and Sexually Transmissible Infections in Australia: Annual Surveillance Report 1999. Darlinghurst, March 1999
13. 13 National Coding Centre. Australian Version of International Classification of Diseases, 9th Revision, Clinical Modification, 2nd edn. Sydney: Faculty of Health Sciences, University of Sydney, 1996
14. 14 Keiser P, Kvanli ME, Turner D, et al. Protease inhibitor based therapy is associated with decreased HIV-related health costs in men treated at a Veterans Administration hospital. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20:28-33
15. 15 Sarazine J, Gail C, Pulvirenti J. Why are HIV infected people hospitalized in the highly active antiretroviral era? (Abstract ThPeB 5086). Program and Abstracts of the XIII International AIDS Conference, Durban, South Africa, July 2000
16. 16 Dhingra R, Munsiff A. The majority of hospitalized HIV patients are not taking HAART (Abstract ThPeB 5087). Program and Abstracts of the XIII International AIDS Conference, Durban, South Africa, July 2000